Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1 study to assess safety, tolerability, pharmacokinetics of AMG 594 in healthy volunteers

Trial Profile

Phase 1 study to assess safety, tolerability, pharmacokinetics of AMG 594 in healthy volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs CK 136 (Primary)
  • Indications Heart failure
  • Focus Adverse reactions
  • Sponsors Amgen
  • Most Recent Events

    • 06 Aug 2020 According to a Cytokinetics media release, the company has completed this study with data analyses going on.
    • 06 Aug 2020 Status changed from suspended to completed, according to a Cytokinetics media release.
    • 14 Apr 2020 Status changed from recruiting to suspended, to protect the safety and health of clinical study participants and healthcare professionals as well as reduce the burden on the healthcare systems fighting COVID-19.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top